RESQ360 Formula
Natural health product licensed in Canada
- Licence holder
- Vivo Brands Inc.
- NPN or DIN-HM
- 80058457
- Status
- Inactive licence
- Licence date
- 25 February 2015
- Revision date
- 18 July 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 50 milligramme | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 50 milligramme | Not calculated |
| Perna canaliculus Source : Viande | 525 milligramme | Not calculated |
| Boswellia serrata Source : Gum oleoresin Extraction ratio : 14:1 Dry plant equivalent : 1,050 milligramme Potency : 30 % 3-Acetyl-11-keto-beta-boswellic acid | 75 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 18,000,000 FCC PU | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 18,000,000 FCC PU | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Cellulose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Helps to support healthy joint mobility and flexibility in person with osteoarthritis and rheumatoid arthritis. Helps to reduce joint pain in persons with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80058457
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging